Plunkett Research Online: Orexigen Therapeutics Inc

OREXIGEN THERAPEUTICS INC (OREX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

exigen Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. The company's lead combination product candidates targeted for obesity are Contrave, which is in Phase III clinical trials and Empatic, which is in .....


OREXIGEN THERAPEUTICS INC

Ticker: OREX
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 858 875-8600
Fax: 858 436-8650
Address: 3344 North Torrey Pines Court
La Jolla, CA 92037 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Michael NarachiCEO/President/Director
Thomas LynchChief Administrative Officer/Executive VP/General Counsel/Secretary
See More
exigen Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. The company's lead combination product candidates targeted for obesity are Contrave, which is in Phase III clinical trials and Empatic, which is in .....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture